Differentiation of HL-60 cells into cells with the osteoclast phenotype.

The osteoclast is the unique multinucleated cell that is responsible for bone degradation in both physiological and pathological circumstances. However, knowledge of the lineage of this inaccessible cell, the nature of its precursors, and the regulation of its formation and activation is limited and controversial. Here we show that the human promyelocytic cell line HL-60 has the potential, under the appropriate culture conditions, to differentiate into cells that have morphological and functional characteristics of osteoclasts, including multinucleation, presence of tartrate-resistant acid phosphatase activity, cross-reactivity with monoclonal antibodies that preferentially recognize osteoclasts, and capacity to resorb bone and respond to calcitonin. The multinucleated cells also contain high affinity receptors to calcitonin, in contrast to wild-type undifferentiated HL-60 cells. These data suggest that osteoclasts share a common precursor with hematopoietic cells. These undifferentiated and differentiated HL-60 cells should provide a unique model for study of the cell biology of human osteoclast differentiation, allowing molecular biological and biochemical studies heretofore not possible.

[1]  T. Yoneda,et al.  Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Miller,et al.  Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. , 1990, Endocrinology.

[3]  I. Kato,et al.  Three cases of oral squamous cancer associated with leukocytosis, hypercalcemia, or both. , 1989, Oral surgery, oral medicine, and oral pathology.

[4]  M. Horton,et al.  The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor , 1989, The Journal of cell biology.

[5]  L. McManus,et al.  Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. , 1989, The Journal of clinical investigation.

[6]  G. Mundy,et al.  Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. , 1988, The Journal of clinical investigation.

[7]  Sheila J. Jones,et al.  Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. , 1988, Endocrinology.

[8]  S. Collins,et al.  The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.

[9]  T. Arnett,et al.  Biological activity of chicken calcitonin: Effects on neonatal rat and embryonic chick osteoclasts , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  P. Sexton,et al.  Chicken osteoclasts do not possess calcitonin receptors , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  E. Burger,et al.  Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  P. Sexton,et al.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. , 1986, The Journal of clinical investigation.

[13]  M. Horton,et al.  Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. , 1985, Cancer research.

[14]  R. Derynck,et al.  Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Peter Ralph,et al.  Human Leukemic Models of Myelomonocytic Development: A Review of the HL‐60 and U937 Cell Lines , 1985, Journal of leukocyte biology.

[16]  A. Boyde,et al.  Resorption of dentine by isolated osteoclasts in vitro , 1984, British Dental Journal.

[17]  P. Reitsma,et al.  Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Fibach,et al.  Self‐renewal and commitment to differentiation of human leukemic promyelocytic cells (HL‐60) , 1982, Journal of cellular physiology.

[19]  E. Abe,et al.  1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). , 1982, The Biochemical journal.

[20]  C. Mundy,et al.  Direct resorption of bone by human monocytes. , 1977, Science.

[21]  T. Rothstein,et al.  Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. , 1977, Journal of immunological methods.

[22]  L. Raisz BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. , 1965, The Journal of clinical investigation.